Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 953.95 Billion | 844.58 Billion | 727.47 Billion | 664.71 Billion | 534.61 Billion | 488.59 Billion |
| Cost of Revenue | 698.75 Billion | 655.41 Billion | 522.6 Billion | 485.3 Billion | 365.41 Billion | 325.17 Billion |
| Gross Profit | 255.19 Billion | 189.16 Billion | 204.87 Billion | 179.41 Billion | 169.19 Billion | 163.42 Billion |
| Operating Expenses | 285.93 Billion | 242.83 Billion | 198.47 Billion | 184.93 Billion | 164.85 Billion | 145.34 Billion |
| Selling, General and Administrative Expenses | 238.83 Billion | 217.94 Billion | 175.86 Billion | 163.98 Billion | 146.49 Billion | 131.12 Billion |
| Research and Development Expenses | 14.61 Billion | 14.35 Billion | 13.04 Billion | 13.45 Billion | 11.58 Billion | 6.77 Billion |
| Other Expenses | - | -10.52 Billion | -9.56 Billion | -7.49 Billion | -6.77 Billion | -7.44 Billion |
| Cost and Expenses | 963.51 Billion | 898.25 Billion | 721.07 Billion | 670.23 Billion | 530.26 Billion | 470.52 Billion |
| Operating Income | -9.42 Billion | -53.66 Billion | 6.39 Billion | -5.51 Billion | 4.34 Billion | 18.07 Billion |
| Interest Expense | 2.17 Billion | 20.86 Billion | 14.53 Billion | 14.91 Billion | 11.4 Billion | 9.71 Billion |
| Income Tax Expense | 8.74 Billion | -1.64 Billion | 11.81 Billion | 3.19 Billion | 14.94 Billion | 185.04 Million |
| Earnings before Tax | 3.18 Billion | -70.53 Billion | -11.46 Billion | -33.44 Billion | 64.23 Billion | 36.59 Billion |
| Net Income | -8.43 Billion | -47.54 Billion | -13.96 Billion | -18.65 Billion | 46.37 Billion | 24.38 Billion |
| Earnings Per Share Basic | -149.80 | -844.95 | -256.29 | -355.41 | 883.66 | 475.18 |
| Earnings Per Share Diluted | -147.73 | -844.95 | -256.29 | -355.41 | 868.72 | 466.04 |
| Weighted Average Shares Outstanding | 56.28 Million | 56.26 Million | 54.5 Million | 52.49 Million | 52.47 Million | 51.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.07 Million | 56.26 Million | 54.5 Million | 52.49 Million | 53.38 Million | 52.33 Million |
| Gross Margin | 0.27 | 0.22 | 0.28 | 0.27 | 0.32 | 0.33 |
| EBIT Margin | 0.07 | -0.02 | 0.05 | 0.03 | 0.05 | 0.07 |
| Profit Margin | -0.01 | -0.06 | -0.02 | -0.03 | 0.09 | 0.05 |
| EBITDA | 70.08 Billion | -16.88 Billion | 30.53 Billion | 6.91 Billion | 98.09 Billion | 61.2 Billion |
| Earnings Before Tax Margin | -0.01 | -0.06 | 0.01 | -0.01 | 0.01 | 0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 264.64 Billion | 232.4 Billion | 240.73 Billion | 953.95 Billion | 237.01 Billion | 239.76 Billion |
| Cost of Revenue | 198.08 Billion | 180.64 Billion | 185.23 Billion | 698.75 Billion | 175.92 Billion | 172.75 Billion |
| Gross Profit | 66.56 Billion | 51.76 Billion | 55.49 Billion | 255.19 Billion | 61.09 Billion | 67 Billion |
| Operating Expenses | 67.33 Billion | 64.36 Billion | 73.51 Billion | 264.61 Billion | 66.14 Billion | 65.43 Billion |
| Selling, General and Administrative Expenses | 59.09 Billion | 58.7 Billion | 65.37 Billion | - | 59.97 Billion | 59.56 Billion |
| Research and Development Expenses | 4.1 Billion | 3.38 Billion | 4.48 Billion | - | 3.79 Billion | 3.17 Billion |
| Other Expenses | -4.13 Billion | -2.27 Billion | -3.65 Billion | -11.17 Billion | -2.38 Billion | -2.69 Billion |
| Cost and Expenses | 265.42 Billion | 245 Billion | 258.75 Billion | 963.37 Billion | 242.07 Billion | 238.19 Billion |
| Operating Income | -776.91 Million | -12.6 Billion | -18.01 Billion | -9.42 Billion | -5.05 Billion | 1.57 Billion |
| Interest Expense | 7.75 Billion | 7.26 Billion | 7.6 Billion | 29.1 Billion | 15.19 Billion | 6.3 Billion |
| Income Tax Expense | 825.29 Million | 768.04 Million | -2.27 Billion | 8.74 Billion | 4.83 Billion | -33.12 Million |
| Earnings before Tax | 10.68 Billion | -15.12 Billion | -23.94 Billion | 369.4 Million | 11.22 Billion | 1.86 Billion |
| Net Income | 2.73 Billion | -14.59 Billion | -16.73 Billion | -8.43 Billion | 5.32 Billion | -2.7 Billion |
| Earnings Per Share Basic | 48.80 | -259.24 | -297.16 | - | 94.60 | -48.03 |
| Earnings Per Share Diluted | -75.98 | -259.24 | -297.16 | - | 94.60 | -44.92 |
| Weighted Average Shares Outstanding | 55.97 Million | 56.31 Million | 56.31 Million | 56.28 Million | 56.27 Million | 56.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.39 Million | 56.31 Million | 56.31 Million | 57.07 Million | 56.27 Million | 60.15 Million |
| Gross Margin | 0.25 | 0.22 | 0.23 | 0.27 | 0.26 | 0.28 |
| EBIT Margin | 0.04 | -0.01 | -0.04 | - | 0.02 | 0.05 |
| Profit Margin | 0.01 | -0.06 | -0.07 | -0.01 | 0.02 | -0.01 |
| EBITDA | 9.67 Billion | -3.22 Billion | -8.59 Billion | - | 4.59 Billion | 11.64 Billion |
| Earnings Before Tax Margin | -0.00 | -0.05 | -0.07 | -0.01 | -0.02 | 0.01 |
CUTLF
3536
028670
CMHHY
ELD
SIGIP